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To investigate the effect of persistent measles virus 
infection on signal transduction in cells of neuronal 
origin, tbe mouse neuroblastoma cell line NS20Y /MS, 
which is persistently infected with measles virus, was 
used. The results demonstrate an approximate 50% 
increase in total phosphorylation and a similar increase 
in protein kinase C (PKC) activity. W estem blot analysis 
with anti-total PKC or anti-PKC-oc antiborlies revealed a 
significant increase in the Ievel of an SOK immuno-
reactive PKC in NS20Y /MS cells. Following incubation 
of NS20Y fMS cells with polyclonal anti-measles virus 
Introduction 
Measles virus (MV), a paramyxovirus, is highly con-
tagious and is one of the major causes of infant mortality 
in underdeveloped countries (Bloom, 1989). Sporadic 
outbreaks of acute measles still occur in industrialized 
countries despite vaccination (Centers for Disease Con-
trol, 1989) and a recent epidemic has caused more than 
100 deaths in North America. MV can cause four distinct 
syndromes in humans: the classical epidemic acute illness 
of children, an autoimmune-like condition known as 
post-infectious encephalomyelitis (Norrby & Oxman, 
1990; Kipps et al., 1983), late and usually fatal 
complications of acute measles infection known as 
subacute sclerosing panencephalitis (SSPE) and measles 
inclusion body encephalitis (MIBE). These complications 
develop as a result of the persistence of measles virus in 
brain cells (Baczko et al., 1984; Basle et al., 1987; Carter 
et a/., 1983; Cattaneo et al., 1987, 1988; Kippset al., 
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antibodies, which down-regulate the Ievel of measles 
virus proteins, total and PKC-mediated phosphorylation 
retumed to the basallevel of uninfected cells. This effect 
was reversible and removal of the antiborlies resulted in 
restoration of the high Ievel of total and PKC-mediated 
phosphorylation. The release of infectious measles virus 
was strongly inhibited by incubation ofNS20Y/MS cells 
with the PKC inhibitor, 1-(5-isoquinolinylsulphonyl)-2-
methylpiperazine (H-7). These results demonstrate that 
measles virus induces elevation in cellular phosphoryl-
ation which is essential for measles virus production. 
1983; Payne et al., 1969). MV replication in the brains of 
SSPE and MIBE patients is characterized by defective 
expression of the viral envelope proteins (Baczko et al., 
1984, 1988; Cattaneo et al., 1988). In these cases the virus 
persists despite the presence of high titres of antiviral 
antiborlies and competent immune cells. 
Protein phosphorylation is a common mechanism for 
the regulation of physiological functions of cells. Many 
key regulatory proteins exist in cells in either a 
phosphorylated or a dephosphorylated form, their 
steady-state Ievels of phosphorylation reflecting the 
relative activities of the protein kinases and protein 
phosphatases that catalyse the interconversion processes. 
These kinases and phosphatases are often targets 
themselves for regulation by protein phosphorylation as 
part of a cascade in signal transduction pathways. The 
basic mechanism for signal transduction is that the 
extracellular signal affects the activity of a protein kinase 
cascade that modulates transcription factor activity by 
phosphorylation and results in alterations in cellular 
gene expression (Karin, 1991, 1992; Nigg, 1990; 
Schwartz & Greenberg, 1987). 
One signal transduction pathway that is of special 
importance in the regulation of brain cell functions uses 
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phosphatidylinositol 4,5-bisphosphate (PIP2) as a pre-
cursor molecule for two second messengers. Ligand 
binding by receptors that operate via this pathway results 
in activation of a phospholipase C that hydrolyses PIP2 
to yield diacylglycerol (DAG) and inositol 1,4,5-
triphosphate (IP3). DAG activates protein kinase C 
(PKC) which Ieads to phosphorylation of numerous 
endogenaus substrates, and IP3 releases Ca 2+ from 
intracellular stores and activates various Ca2+-dependent 
enzymes (Berridge, 1987). PKC is a ubiquitous calcium/ 
lipid-dependent enzyme which phosphorylates a variety 
of membrane, cytosolic and nuclear proteins on serine/ 
threonine residues (for reviews see Nishizuka, 1986a, b, 
1988, 1992). PKC exists as a family of at least eight 
structurally and functionally related isoenzymes with 
minor differences in enzymatic properties, substrate 
specificity and tissue distribution (Kikkawa et al., 1987; 
Kuo et a/., 1986; Huang et al., 1986, 1988; Huang, 1989; 
Ono et al., 1988; Akita et a/., 1990; Sekiguchi et al., 
1987; Coussens et a/., 1986). Physiologically, PKC is 
activated by endogenaus DAG in response to occupation 
of membrane receptors by the appropriate Iigand 
(Nishizuka, 1986a, 1988; Huang, 1989). An enzymatic-
ally active PKC binds tightly to membranes (Kikkawa et 
al., 1982). This phenomenon, known as translocation, 
designates activation of the enzyme. 
Taking into account the principal role of phosphoryl-
ation processes and PKC activity in neuronal functions, 
one may suggest that any alteration in this enzyme's 
activity will result in impairment of the normal function 
of these cells. Indeed, changes in PKC activity have been 
observed in various patho-physiological conditions. For 
instance, in short- or long-term forebrain ischaemia, 
translocation ofPKC from cytosol to membranes and its 
subsequent downregulation have been observed (Louis 
et al., 1988, 1991; Wielochet a/., 1991). Enhanced PKC 
activity and alterations in its distribution, as weil as 
phosphorylation of a neuron-specific PKC substrate, 
were found in the neocortex of patients at early stages of 
Alzheimer's disease (Clark et al., 1991; Florez et al., 
1991; Masliah et al., 1991). Several studies have indicated 
that viral infection may indeed affect phosphoinositide 
(PI) turnover and the phosphorylating activity of PKC. 
Mouse fibroblasts infected with herpes simplex virus 
type 2 exhibited elevated PKC activity (Roddick et al., 
1988), whereas mouse fibroblasts infected with human T 
cellleukaemia virus or adenovirus exhibited an increased 
turnover of PI (Nevins, 1989; Tan et al., 1989). 
To investigate the effects of persistent MV infection on 
cells of the centrat nervaus system we have used a mouse 
neuroblastoma cell line persistently infected with MV, 
NS20Y /MS (Rager-Zisman et al., 1984). This cell line 
was established from clone NS20Y ofthe CI300 murine 
neuroblastoma which is capable of differentiating in vitro 
and retains neuron-specific enzymes and receptor 
markers (Augusti-Tocco & Sato, 1969; Oldstone et al., 
1977). Recent studies by Schneider-Schaulies et al. (1992) 
have also demonstrated that the restriction of MV gene 
expression in these cells is similar to that found in brain 
cells of SSPE patients and experimentally infected rats. 
Our previous studies demonstrated that NS20Y /MS 
cells exhibit elevated PKC activity and augmented 
expression of the c-fos proto-oncogene (Wolfson et al., 
1991). 
The present study was undertaken to investigate the 
regulation of protein phosphorylation and PKC activity 
in NS20Y jMS cells. We demonstrate that the enhanced 
total cellular phosphorylation and PKC activity could be 
downregulated by treatment of the persistently infected 
cells with polyclona1 anti-MV antibodies. Following 
treatment of infected cells with these antibodies, but not 
with monoclonal antibodies, total and PKC-mediated 
protein phosphorylation returned to the basal Ievels of 
uninfected neuroblastoma cells (NS20Y). In addition we 
have shown that inhibition of PKC activity by l-(5-
isoquinolinylsulphonyl)·2-methylpiperazine (H-7) de-
creased the release of infectious virus from these cells. 
These results suggest that the enhanced phosphorylating 
activity of persistently infected cells is induced by the 
virus and that PKC-mediated phosphorylation plays an 
important role in the maturation of infectious MV 
particles. 
Methods 
Cel/s and viruses. The Cl300 neuroblastoma. clone NS20Y. of the 
A/J mause strain was used. The establishment of MV persistently 
infected NS20Y cells termed NS20Y /MS is described in detail 
elsewhere (Rager-Zisman et a/., 1984). Cells were routinely grown in 
RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf 
serum (FCS), glutamine and antibiotics. 
Antibodies. Polyclonal anti-MVhyperimmune serumwas raised in 
rabbits by immunization with antigen in complete Freund's adjuvant, 
followed by repeated intramuscular injections with solubilized virus 
alone (Ju et al .. 1978). The preparation and characterization of 
monoclonal antibodies against measles virus N protein were described 
by Birrer et a/. (1981) and against H protein (NC32) by Carter et al. 
(1983). Polyclonal rabbit anti-PKC antibodies were prepared as 
described previously (lsakov et al., 1990). Monoclonal anti-bovine 
spieen PKC~ antibodies were purchased from Seikagaku. 
Measurement of total phosphorylation and PKC activity. Total 
phosphorylation and PKC activity were determined in cytosolic and 
particulate fractions. Cytosolic fractions were obtained by the following 
procedure. Cells were resuspended in an extraction buffer containing 
20 mM-Tris-HCI pH 7·5, 1 mM-PMSF. 2 mM-EGTA and 10 mM-DTT, 
disrupted by sonication on ice and centrifuged for 30 min at 20000 g. 
The supernatant was designated the cytosolic fraction. To obtain 
membrane-associated proteins. corresponding pellets were extracted 
for I h on ice in the same buffer containing 1% Triton X-100. After 
centrifugation at 20000 g for 30 min the resulting supernatant was 
designated the particulate fraction. Both fract10ns were further purified 
by chromatography on DE52 cellulose columns (Whatman) (Thomas 
et a/., 1987). Histone Hl was used as an exogenaus substrate, 
[y-32P]ATP (NEN, sp. act. 10 to 50 Ci/mmol) as the phosphate group 
donor and DAG. pbosphatidylserine (PS) and CaCl2 as PKC activators 
(Kikkawa et a/., 1982; Wolfsan et al .• 1985). The standard assay 
mixture (0·2 ml) contained 20 mM-Tris-HCl pH 7·5, 10 mM-DTT, 
0·4mM-EGTA, 10 lllM-MgC12• 1 mM-CaCI2, 2llg/ml DAG and 80 1-Lg/ 
ml PS, histone Hl (30 j..Lg/ml) and [y-32P]ATP (2 x 106 c.p.m.jassay, in 
a final concentratlon of 50 llM). Where indicated, 50 nM-phorbol 12-
myristate 13-acetate was used instead ofDAG. Optimal concentrations 
of the activators were determined in preliminary experiments. After 
3 min incubation at 30 °C, the reaction was stopped by the addition of 
25% TCA and the reaction mixture was filtered through nitrocellulose 
filters (0·45 j..Lffi) in a dot blot apparatus. The nitrocellulose filter was 
washed three times with cold I 0% TCA, dried, cut and 32P 
incorporation was measured by liquid scintillation counting. Assays 
were performed in duplicate in the presence or absence of calcium and 
Iipids. Enzymatic activity was measured as the incorporation of 32P 
from [y-32P]ATP into histone H 1. Activity is expressed as picomoles of 
32P incorporated per min per mg of sample protein. Total phosphoryl-
ating activ1ty was calculated in the same units in the absence of PKC 
cofactors (calcium or Iipids). Net PKC activity was calculated by 
subtracting the activity measured in the absence of the cofactors from 
that measured in the presence of cofactors. Calculation of the 
cytosol: particulate ratio is used to demoostrate enzyme translocation. 
Endogenaus protein phosphorylation in vitro. For analysis of total 
protein phosphorylation. cell suspensions were washed twice with PBS. 
resuspended in extraction buffer. disrupted by sonication on ice and 
centrifuged for 30 rnin. Reactions were initiated by the addition of 
[y-32P]ATP as the phosphate group donor (2 x 106 c.p.m.jassay in a 
final concentration of 50 mM), for 3 min at 30 °C. The reaction was 
terminated by bo1hng for 5 min in 2 x SDS sample buffer as described 
by Laemmli (1970). Phosphorylated samples containing 150 to 200 ll8 
protein were then separated by 10% SD~PAGE for 18 h. Gels were 
dried and the phosphorylated proteins were detected by autoradi-
ography. 
For analysis of PKC-mediated phospborylation. the same reaction 
mixturewas used with the addition of2j..Lgjml DAG, 80 j..Lgjml PS and 
I mM-CaCI~ as PKC cofactors. 
Western blotting. For protein analysis cell extracts were prepared in 
cold RIPA buffer [(50 mM-Tris-HCl pH 7·5, 0·25% w jv sodium 
deoxycholate, 0·1% wjv SDS and 0·5% wjv NP40). Extracts were 
mixed with 2 x sample buffer and boiled for 5 min. Then 150 to 200 llg 
portions of sample protein were loaded in each gellane and subjected 
to 10% SD~PAGE. The resolved proteins were transferred electro-
phoretically to nitrocellulose filters which were then blocked for 1 h in 
PBS containing 10% low fat dry milk, followed by 1 h incubation with 
the first antibody diluted in PBS containing 1 % dry milk. The filters 
were washed three times in PBS and the immunoblots were incubated 
with peroxidase-conjugated second antibody for 1 h, washed three 
times with PBS and developed with 4-chloronaphthol (0·3 mgjml) and 
H202. 
Treatment of cells with anti-MV antibodies. For antibody treatment, 
the medium of semiconfluent cultures was replaced witb fresh medium 
containing anti-MV polyclonal or monoclonal antiborlies sufficient to 
neutralize 10~ p.f.u. of MV. Every third day, the cells were split and 
fresh medium containing antiborlies was added. Antibody-treated or 
untreated cells were harvested at different times after antlbody 
treatment. For reactivation, the cells were cultured in medium without 
antiborlies and harvested at different times after antibody removaL 
Treatment ojcells wuh H-1. To study its effect on virus release, H-7 
(dissolved m DMSO) was added to conßuent cell cultures. 24 h after 
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subculture. at a final conccntration of 100 j..LM. Twenty-four hours later. 
supernatants were collected and used for titration of the v1rus. The 
solvent (DMSO) had no effect on the virus release at the concentration 
used in the experiments. 
Virus titratwn. The titres of virus in culture supernatants were 
determined by a semiquantitative plaque assay (Rager-Zisman et al., 
1984). Vero cell monolayers were trypsimzed and plated in 24-well 
plastic trays. Cells (3 x 10°) were seeded in each weiland incubated at 
37 °C overnight. Tenfold dilutions of virus samples were prepared in 
Dulbecco's MEM supplemented with 2% FCS. The growth medium 
from each weil was aspirated, and duplicate wells were inoculated with 
0·2 ml of viral dilutions. After an adsorption period of 2 h at 33 °C, 
1 ml of growth medium containing 0·75% carboxymethyl cellulosewas 
added. The monolayers were then incubated at 37 °C for 5 days. fixed 
with 10% formol-saline and stained with crystal violet. 
Results 
In vitro phosphorylation of endogenous profeins in 
NS20 Y IM S cells 
The effect of MV persistent infection on total protein 
phosphorylation was investigated by measuring in vitro 
incorporation of 32P into proteins as described in 
Methods. The results demonstrate a 50% increase in 
total phosphorylating activity in the cytosolic fraction of 
infected cells NS20Y jMS, as compared with uninfected 
NS20Y (Fig. 1 a). Separation of the phosphorylated 
proteins by SDS-PAGE showed an overall increase in 
phosphorylation of endogenaus protein substrates in 
NS20Y /MS cells (Fig. 1 b). 
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Fig. 1. Total protein phosphorylation activity in NS20Y and 
NS20Y JMS cells. (a) Phosphorylation of histone Hl by cytosolic 
extracts ofNS20Y or NS20Y JMS cells. (b) In vitro endogenaus protein 
phosphorylation of crude cytosolic extracts incubated with [32P]A TP 
for 3 min, followed by SOs-PAGE. Gels were dried and phospho-
proteins were visualized by autoradiography. Lane l, NS20Y; lane 2, 
NS20Y JMS. Results were representative of at least six experiments. 
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Table 1. PKC activity in NS20YjMS and NS20Y cells* 
Increase Cytosolic: 
Ce II Fraction TPA DAG (%) particulate 
NS20Y Cytosol 364± 11 329±34 
NS20Y/MS Cytosol 564±27 523±31 37% 1·28 
NS20Y Particulate 278± 18 256±43 
NS20YjMS Particulate 426± 17 396±25 36% 1·32 
• Endogenaus activity of PKC (pmoljminjmg protein) was measured in the cytosolic and 
particulate extracts ofNS20Y and NS20Y jMS cells as described in Methods. TPA (50 nM) or DAG 
(2 flgfml) were added to the reaction m1xture and PKC activity was determined on 50 mg protein 
samples. Results are the mean of three experiments±s.D. 
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Fig. 2. PKC-mediated phosphorylation in NS20Y or NS20Y jMS cells. 
Lanes 1, uninfected cells; lanes 2, MV-infected cells. (a) PKC activ1ty 
was measured in a reaction mixture specific for PKC with histone Hl 
(30 f.lg/rnl), DAG (2 flgfml) and PS (80 flgfml), as described in 
Methods. The proteins were then separated by SDS-PAGE and 
subjected to autoradiography. PKC proteinwas detected by Western 
blotting as described in Metbads using polyclonal rabbit anti-PKC 
antibodies (b) or monoclonal anti-PKC-~ antibodies (c). 
Protein kinase C-mediated activity and phosphorylation 
in NS20Yj MS cells 
To examine the extent of phosphorylation mediated by 
PKC. we assayed the activity of these enzymes using 
either DAG with PS or TPA with PS as specific PKC 
cofactors. The results summarized in Table 1 dem-
onstrate an increased PKC activity in both fractions of 
NS20Y jMS cells being 37% and 36% in cytosolic and 
particulate fractions, respectively. The ratio of 
cytosolic: particulate PKC activity remained practically 
unchanged, 1·32 in NS20Y /MS cells and 1·28 in 
uninfected NS20Y cells. These results indicate that the 
accumulation of viral proteins in NS20Y jMS cells did 
not have an effect on the subcellular distribution ofPKC. 
PKC-mediated phosphorylation of endogenaus pro-
tein substrates in vitro was studied next. Cellular extracts 
were incubated with the PKC reaction mixture and 
(y-32P]ATP as described in Methods and the phosphoryl-
ated proteins were separated by SDS-PAGE. In these 
experiments PKC-mediated phosphorylation was detec-
ted in both cell types; nonetheless, it was substantially 
higher in NS20Y jMS cells. In extracts of MV -infected 
cells intensely phosphorylated proteins ranging in Mr 
from 27K to 60K were observed (Fig. 2a, compare lane 
1 with lane 2). To test whether phosphorylation was 
associated with viral proteins, MV proteins were im-
munoprecipitated from NS20Y jMS cell extracts using 
polyclonal rabbit anti-MV antibodies. No phosphoryl-
ated viral proteins were detected (data not shown). 
To test whether the augmented activity of PKC is 
reflected by an increase in PKC synthesis, immuno-
blotting was performed with polyclonal anti-PKC or 
monoclonal anti-PKOx antibodies. The results, shown in 
Fig. 2(b) and (c) respectively, revealed a significant 
increase in the detected Ievel of the 80K PKC proteins 
expressed in NS20Y jMS cells with both antibodies. 
Dmtnregulation of total prorein phosphorylation activity 
in NS20YjMS cells by anti-MVantibodies 
In the following experiments the effect of anti-MV 
antibody treatment on total phosphorylating activity in 
cytosolic fractions of NS20Y /MS cells was investigated. 
Cells were grown in the presence of polyclonal anti-MV 
antibodies under conditions shown to downregulate MV 
protein synthesis (Schneider-Schaulies et al., 1992). A 
decrease in total phosphorylating activity was first 
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Fig. 3. Downregulation of total protein phosphorylation by anti-MV 
antibodies. Cells were grown in the presence of polyclonal anti-MV 
antibodies (solid line). Total phosphorylation activity was determined 
at different times during antibody treatment in the cytosolic fraction by 
using a standard kinase assay. Recovery of the Ievel of total protein 
phosphorylation following growth in the absence of antibody is 
indicated by a broken line. Data are representative of three independent 
assays. 
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Fig. 4. Downregulation of PKC activity by anti-MV antibodies. Cells 
were grown m the presence of polyclonal anti-MV antibodies. PKC 
activity was determined, at various times during antibody treatment, in 
the cytosolic fraction as described in Methods. PKC activity in NS20Y 
cells was taken tobe 100%. (A) untreated NS20Y /MS cells; (B) 2 days 
and (C) 6 days of growth in the presence of antiborlies; (D) 6 days with 
antiborlies followed by 14 days growth in the absence of antibodies. 
The results are the mean of four independent experiments. In all cases 
these determinations did not differ by more than 10%. (0). NS20Y 
cells, (~). NS20Y fMS cells. 
detected after 2 days of treatment with anti-MV 
antibodies and reached the baseline Ievels of uninfected 
cells after 4 to 6 days (Fig. 3). This effect was reversible 
since the original Ievel of phosphorylating activity of 
NS20Y jMS cells was gradually restored when the 
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Table 2. Effect of H-7 on MV release by NS20Y/MS 
cells 
Virus 
Cell Treatment release* 
NS20Y None 
NS20Y H-7 
NS20YJMS None 1·5 X 103 
NS20YJMS H-7 7·0 X 10° 
* Cells were incubated with 100 J.lM-H-7 for 24 h. Virus release, 
expressed in p.f.u.jml, was detennined by plaque formation on Vero 
cells, as described in Methods. 
cultures were grown in fresh medium without antibodies. 
Treatment of the cells with either anti-H or anti-N 
protein monoclonal antibodies or polyclonal antiserum 
non-specific for MV had no such effect. 
Downregulation of PKC activity in NS20YJMS cells by 
anti-MV antibodies 
Next we investigated whether the enhanced PKC activity 
in NS20Y jMS cells could also be modulated by 
treatment with anti-MV antibodies. As was mentioned 
above, PKC activity was higher in NS20Y jMS than in 
NS20Y cells. Reduction in PKC activity was observed on 
the second day of antibody treatment (Fig. 4, compare B 
with A) reaching the Ievel of PKC activity in NS20Y cells 
by day 6 (Fig. 4, C). Removal of the antibodies and 
growth of the cells for an additional 14 days resulted in 
the restoration of PKC activity almost to the original 
Ievel of NS20Y /MS cells (Fig. 4, D). Treatment of the 
cells with monoclonal anti-H or anti-N protein anti-
hodies had no such effect (data not shown). 
Inhibition of MV re/ease by H-7 
To study the involvement ofPKC in the life cycle of MV, 
the release of infectious virus from NS20Y jMS cells was 
measured after treatment with H-7. NS20Y /MS cells 
were cultured in the presence or absence of 100 J.l.M-H-7 
for 24 h. As can be seen from Table 2, the yield of 
infectious virus was strongly inhibited, decreasing from 
1·5 x 103 to 7 x 10° p.f.u. in the presence of H-7. The 
compound had no effect on the Ievel of MV proteins as 
measured by Western blot analysis of cell extracts (data 
not shown). These results may indicate that there is an 
intimate relationship between PKC-mediated phos-
phorylation and the assembly and budding of infectious 
MV particles. 
Discussion 
Clone NS20Y jMS of the murine neuroblastoma Cl300 
was infected with the wild-type Edmonston strain of MV 
and, after transition to a carrier culture, became 
824 Y. Segev and others 
persistently infected (Rager-Zisman et al., 1984). The 
cultures maintained a morphology indistinguishable 
from that of the parental uninfected NS20Y cells; 
nonetheless, immunofiuorescence studies revealed ac-
cumulation of viral proteins in the majority of cells. We 
have previously investigated the effect of persistent MV 
infection of NS20Y cells and have shown that NS20Y I 
MS cells are less tumorigenic and express enhanced 
amounts of major histocompatibility complex class I 
glycoproteins (Gopas et al., 1992). In addition increased 
expression of the c-fos proto-oncogene and PKC genes 
was also detected (Wolfson et a/., 1989, 1991). 
In the present report we demonstrate that an intimate 
relationship exists between the synthesis of MV proteins 
and an increase in the phosphorylating activity as 
detected in the persistently infected cells. The endogenous 
phosphorylating activity in NS20Y IMS cells was 50% 
higher than that in the uninfected cells. The increase in 
total protein phosphorylation suggests that several 
kinases may be activated by MV. In this context we have 
recently shown that the activity of a dsRNA-dependent 
kinase was significantly elevated in NS20Y IMS cells 
(Gopas et al., 1992). Wehave shown previously that the 
increase in PKC activity paralleled the elevation of PKC 
gene expression (Wolfson et al., 1989, 1991). Here we 
con:firm this observation at the protein Ievel, dem-
onstrating an increase in the 80K protein detectable by 
using anti-total PKC or anti-PKOx antibodies. It 
appears that MV requires a PKC-mediated phosphoryl-
ation step as shown for other viruses including human 
immunodeficiency virus (Chowdhury, et al., 1990; Kinter 
et al., 1990) and bovine leukaemia virus (Jensen et al., 
1992). 
In the present study we show that although the extent 
of phosphorylation of endogenaus proteins was con-
sistently higher in NS20Y IMS cells, differences between 
the protein substrates could not be detected, indicating 
that these were primarily cellular proteins. In contrast, 
when PKC-mediated phosphorylation was examined, 
additional species of phosphorylated proteins could be 
observed in NS20Y IMS cells. The Mrs of these proteins 
were between 30K and 80K, similar to those of MV 
proteins. The results of immunoprecipitation with anti-
MV antiborlies were negative suggesting that the phos-
phorylated proteins are of cellular origin and that their 
phosphorylation is induced by the virus. Although it is 
weil established that MV proteins P, N and V are 
phosphorylated, from this study it appears that PKC is 
not involved in this process. Another serine kinase, such 
as casein kinase li, shown by Barik & Banerjee ( 1992) to 
phosphorylate the P protein of vesicular stomatitis virus, 
is a probable candidate. The strong corre1ation found 
between the high MV protein content and both Ca 2+ I 
lipid-dependent or -independent phosphorylating ac-
tivity may indicate that MV infection can directly or 
indirectly mediate the activity of these kinases. The 
mechanism underlying this effect is as yet unknown 
although it has been described for a variety of DNA and 
RNA viruses, including polyoma virus, hepatitis B virus, 
adenovirus, herpes simplex virus, and human T cell 
leukaemia virus types I and li (De Wind et al., 1992; 
Giordano et al., 1991 ~ Nevins, 1989, 1991; Shiroki et a/., 
1992; Suzuki et a/., 1992; Tan et al., 1989; Yoakim et a/., 
1992; Maguire et al., 1991; Wu et al., 1990; Can & Chen, 
1990). 
We have shown recently that binding of polyclonal 
antibodies against MV or a mixture of monoclonal anti-
H protein antiborlies to NS20Y IMS cells resulted in 
downregulation of MV mRNA and protein synthesis 
(Schneider-Schaulies et al., 1992). When the effect of this 
treatment on total phosphorylation or PKC activity was 
examined, downregulation occurred only when poly-
clonal antiborlies were used. Treatment of the infected 
cells with antiborlies against the intracellular N protein 
also had no such effect and in this case it appears that 
binding to a membrane entity is required. Furthermore it 
also appears that, in order to downregulate total 
phosphorylation or PKC activity, binding to more than 
one viral epitope is required since treatment with a single 
anti-H monoclonal antibody that binds and neutralizes 
MV bad no effect. In this context, it is worth noting that 
monoclonal antiborlies that bind to the same antigen 
may recognize epitopes with different structures since 
their binding sites are distinct in shape (Simpson et al., 
1993). Therefore, it seems possible that binding to more 
than one epitope is essential for inducing the conform-
ational changes that will trigger the intracellular sig-
nalling. 
The nature of the transduction pathway involved in 
the delivery of the signal triggered by the binding of anti-
MV antibody is still unknown. Weinemann-Dorsch & 
Kosehel (1989) reported that treatment of rat glioma 
cells, persistently infected with the SSPE strain of MV, 
with anti-MV antibodies stimulated phosphatidylinositol 
breakdown and inositol phosphate formation 
(Weinemann-Dorsch & Koschel, 1989; Tas & Koschel, 
1991). Alterations in PIP2 metabolism do not necessarily 
result in the activation of PKC, and because in these 
experiments PKC activity was not measured it is difficult 
to compare the results of both systems. 
Modulation of viral protein synthesis and cellular 
phosphorylation by anti-MV antibodies in NS20Y /MS 
demonstrates that there is a dynamic equilibrium 
between the persistent virus state and cellular metabo-
lism. Viruses often use cellular phosphoprotein kinases 
to phosphorylate their own proteins in order to activate 
their functions. Exarnples of this include potentiation of 
the v-fms transforming potential of feline sarcoma virus 
by phosphorylation on threonine-939, phosphorylation 
of the v-erb A on serine 161 11 which is essential for its 
oncogenic potential, and reactivation of herpes simplex 
virus type 1 from latency by PKC activators (Glineur et 
al., 1990; Leib et al., 1991; Tamura et al., 1991). 
Although MV neither transfonns the cells nor causes 
immortalization. phosphorylation may be a necessary 
step in its replication. lt was indeed reported that TPA, 
which strongly activates PKC, was a very strong inducer 
of productive MV infection in peripheral blood mono-
cytes (Vanionpää et al., 1991). These results are in 
agreement with our Observation that treatment with H-7 
decreased the release of infectious virions. Treatment 
of NS20Y /MS with H-7 for 24 h led to a profound 
inhibition of the release of infectious MV. This suggests 
that phosphorylation mediated by PKC andjor other 
kinases such as protein kinase A, is an essential step in 
assembly and maturation of the virions. 
In conclusion, the results presented here suggest that 
the augmented PKC activity is a necessary step in the 
maintenance of the persistent infection as weil as in viral 
maturation. It is proposed that viral antigens expressed 
on the hast cell membrane behave as receptors trans· 
ducing signals to maintain viral replication without 
affecting cell viability. 
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